Ovarian serous tumor
MONDO:0037255A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that, in well differentiated tumors, resemble the epithelial cells of the fallopian tube and, in poorly differentiated tumors, show anaplastic features. Approximately thirty to fifty percent of the tumors are bilateral. Grossly, the better differentiated tumors consist of cystic masses, usually unilocular, containing a clear but sometimes viscous fluid. Papillary formations are often present. The more malignant tumors tend to be solid and invasive, with areas of necrosis and hemorrhage.
Also known as: ovarian serous neoplasm, ovarian serous tumor, serous neoplasm of ovary, serous neoplasm of the ovary, serous tumor of ovary, serous tumor of the ovary, serous tumour of ovary, serous tumour of the ovary
1629 clinical trials for this condition and its sub-types, 6 tagged with Ovarian serous tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian serous tumor
-
Malignant ovarian serous tumor 5 trials · 202 incl. sub-types
1 sub-type
- Ovarian serous adenocarcinoma 198 trials · 202 incl. sub-types Sub-types →
-
Borderline ovarian serous tumor 11 trials
Most studied deeper sub-types
-
Could a natural pill prevent blood clots in ovarian cancer patients?
Disease control Recruiting nowThis study tests whether a daily pill called isoquercetin, made from a plant compound, can reduce blood markers linked to clot risk in people with ovarian cancer. About 90 participants receiving chemotherapy will take either isoquercetin or a placebo for up to 6 weeks. The goal i…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Ovarian cancer: can a second round of niraparib after surgery keep tumors at bay?
Disease control Recruiting nowThis phase 2 trial is testing whether giving the drug niraparib again after surgery can help women with ovarian cancer whose disease has come back in just a few spots. About 30 participants will take niraparib pills daily until their cancer grows or side effects become too much. …
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a nurse check on you from home? new study tests remote monitoring for rare cancers
Knowledge-focused Recruiting nowThis study looks at whether follow-up care for people with rare tumors can be done just as well by a nurse remotely as by a doctor in person. About 88 adults recently diagnosed with a rare tumor will be randomly assigned to either in-person doctor visits or remote nurse check-ins…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC